Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Tobradex Eye Drop Suspension vs Tobramycin/Dexamethasone Ophthalmic Suspension

NCT03975374 is registered in ClinicalTrials.gov with Sutphin Drugs as lead sponsor.

NCT NCT03975374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03975374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Tobradex Eye Drop Suspension vs Tobramycin/Dexamethasone Ophthalmic Suspension
Lead sponsor
Sutphin Drugs
Phase
Phase 1
Overall status
Unknown status
Start date
June 15, 2019
Completion date
June 30, 2020
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blepharo conjunctivitis